Nordson 2025 Q3 Earnings Strong Performance as Net Income Surges 7.2%

Nordson (NDSN) reported its fiscal 2025 Q3 earnings on Aug 20th, 2025, showcasing robust financial performance across key metrics. The company delivered a 12.1% revenue growth and an 8.8% increase in EPS, surpassing expectations. Nordson also reaffirmed its full-year guidance, indicating confidence in its business momentum amid market uncertainties.

Nordson’s total revenue in the third quarter of 2025 climbed to $741.51 million, a 12.1% increase from $661.60 million in the same period of the previous year. The Industrial Precision Solutions segment led the charge with $350.78 million in revenue, reflecting strong demand for high-performance fluid handling solutions and advanced dispensing technologies. The Medical and Fluid Solutions segment contributed $219.47 million, driven by steady growth in healthcare and life sciences applications. Meanwhile, the Advanced Technology Solutions segment reported $171.26 million, showing robust performance in specialty markets such as aerospace and semiconductor. Corporate operations did not contribute to revenue.

Nordson’s earnings performance was equally impressive, with earnings per share (EPS) rising 8.8% to $2.23 in 2025 Q3 from $2.05 in 2024 Q3. The company’s net income also increased by 7.2% to $125.78 million compared to $117.33 million in the prior-year period. These results reflect the company’s ongoing operational efficiency and cost discipline, which have enabled profitability for over 20 years during the corresponding fiscal quarter.

The stock price of Nordson declined modestly in the short term, falling 1.38% during the latest trading day, 3.64% over the most recent full trading week, and 0.36% month-to-date. This post-earnings price movement highlights the mixed investor sentiment.

The strategy of buying Nordson (NDSN) shares immediately after the earnings report and holding for 30 days yielded a -6.46% return, significantly underperforming the 53.10% benchmark return for the same period. This negative excess return of -59.56% and an annualized CAGR of -2.28% over three years indicates a challenging investment outlook for the strategy, despite the company’s strong earnings.

Nordson Corporation President and CEO Sundaram Nagarajan expressed confidence in the company’s trajectory, attributing the success to operational excellence and strategic initiatives like the Atrion acquisition and the NBS Next initiative. These efforts have enhanced product innovation and customer responsiveness. The CEO highlighted a 13% rise in adjusted EPS and 15% growth in EBITDA, alongside strong cash flow conversion that supports debt reduction and shareholder returns. He emphasized the company’s resilience and optimism about its ability to deliver long-term value amid shifting market conditions.

Looking ahead, Nordson expects to meet its original full-year sales and earnings guidance, contingent on the completion of a pending medical contract manufacturing business divestiture in Q4. While sales are tracking slightly below the mid-point of guidance, adjusted earnings per share are above expectations. The company’s outlook remains stable, supported by its diversified product portfolio and customer-centric strategy.

Additional News
In Nigeria, Chinese diplomats recently deepened economic ties by visiting an Ogun state trade zone, highlighting growing international engagement in the country’s business ecosystem. Meanwhile, Google, Microsoft, and TikTok announced the blocking of 13.5 million accounts in Nigeria as part of their efforts to combat spam and malicious activity. Political tensions also escalated, with reports of a rift between PDP leaders Wike and Makinde, raising concerns over the party’s unity ahead of the 2027 elections.